MedPath

Treatment Of Peripheral Neuropathy In Diabetic Patient

Phase 2/3
Not yet recruiting
Conditions
Polyneuropathy in diseases classified elsewhere. Ayurveda Condition: Madhumeha Upadrava, (2) ICD-10 Condition: G64||Other disorders of peripheral nervous system. Ayurveda Condition: MADHUMEHAKUSHTHINO ASTHAPANAVYAPADAH,
Registration Number
CTRI/2023/09/058085
Lead Sponsor
Taranath Government Ayurvedic Medical College And Hospital Bellary
Brief Summary

Summery Of the Study



Diabetic Peripheral Neuropathy is a type of nerve damage that can occcur with diabetes and is most common complication of diabetic mellitus with a lifetime prevalence of about 50-70%.patients of diabtes will lose their sensation in the feet,burning sensation and weakness along with pain.Neuropathy is a coomon complication of diabetes mellitus patient affecting approximately 305.although the invention of insulin and hypogycemia have done a great service for diabetes,yet these patients dont get a proper solution for their neuropathic complications.



The Drugs Used conventionally are mostly for relief in the symptoms and moreover they have certain side effects so it is necessary to explore the possibilities of safer and effective treatment from other sources

The Symptomology correspomding to the clinical presentation of Diabetic Peripheral Neuropathy is scattered in purvaroopa,lakshana,upadrava of Prameha,Vatarakta,Vatavyadhi,Jwara,Pandu.



Madhutailika Basti as it is indicated in Prameha,acts as Deepana,Bramhana,Atyanta Vrushya,Balavarnakara,Upadrava Rahita and Rasayana.



Siravyadha Relieves Suptivata,Padadaha,Padaharsha,Vatashonita. and Whenthere is a pathology of vatarakta along with ruja ,daha,toda,supti asraksravya is indicated.



Vatari Rasa is Vatakapha rogahara,and indicated in Vatarakta,Prameha,Shula,Vatavyadhi.



Shilajatu Rasayana is Sarvapramehahara.



Madhumeha and Diabetic Peripheral Neuropathy are big challenges in medical practice.the research question will more focusing on madhumeha upadrava chikitsa by raktashodhana,basti to control neurovascular integrity and rasarasayana has any positive effect in Diabetic Peripheral Neuropathy on correct evidence based clinical kayachikitsa parameters.hence the presence study entitled



AN OPEN LABELLED RCT STUDY ON ASESSMENT OF COMBINED EFFICACY OF SIRAVYADHA,MADHUTAILIKA BASTI,VATARI RASA AND SHILAJATU RASAYANA IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY(MADHUMEHA UPADRAVA)



OBJECTIVES OF STUDY



1.To Study The Effect Of Siravyadha,Madhutailika Basti,Vatari Rasa,Shilajatu Rasayana In The Managemnt of Diabetic Peripheral Neuropathy.



2.To Asess The Effect Of Modern On Going Intervention In The Management Of Diabetic Peripheral Neuropathy.



3.To Compare The Effect Of Siravyadha,Madhutailika Basti,Vatari Rasa And Shilajatu Rasayana Over Modern On Going Intervention In The Management Of Diabteic Peripheral Neuropathy



STUDY DESIGN



Study Design-Randemised,Standerd Controll,Open And Comparative



Estimated Enrollment-40



Allocation-Randemised



Masking-Open



Study Duration-42 Days



Follow Up After-15 Days



ASSESSMENT CRITERIA



On The Basis Of Subjective And Objective Criteria



Subjective Criteria



1.RUJA(Grade 0=does not complaint of nerve pain,no nerve pain even when asked about it,Grade 1=complaint of nerve pain even when not asked about it,Grade 2=complaint of severe nerve pain and points to the areas of its radiation.the pain does not interfere with sleep.it is aggravated by repeated use of the limb such as manual labour,tailoring etc,Grade 3=says pain is severe,and that it interferes with sleep,the patient keeps the limb in apposition of rest and avaoids its movement



2.HASTAPADA SUPTATA(Grade 0=parasthesia and /decreased tendon reflexs,Grade1 =severe parasthesia and/mild weakness,Grade 2=intolerable parasthesia amd/marked motor loss,Grade 3=paralysis)



3.HASTAPADA DAHA(Grade 0=no burning sensation,Grade 1=occassionally burning sensation,Grade 2=often burning sensation,Grade 3=always burning sensation(disturbing sleep and other activities)



4.Dourbalya(Grade 0=no sign or symptoms,Grade 1=asymptomatic,weakness on examination and testing normally,Grade 2=symptomatic,weakness interfering with function but not interfering ADL,Grade 3=weakness interfering with ADL,Grade 4=life threatening /disabling(paralysis))



5.CHIMICHIMAYANA(Grade 0=none,Grade 1=symptoms from toes to midfoot,not including heel,Grade 2=symptoms from midfoot to ankle,Grade 3=symptoms extend above ankle to knee without upper extremity symptoms,Grade 4=symptoms above knee/concurrent lower and upper extremity symptoms)



Objective Criteria



1.A Standard TORANTO Clinical Scoring System Is Selected For Asessing The Peripheral Neuropathy



2.NCS(Nerve Conduction Study)( Based On Symptom Score,Reflexes,Sensory Test Score,Result)



3.Vitamin B12



4.CRP



5.HBA1C



INVESTIGATION



1.HB%,TC,DC,ESR,CRP,PT INR

2.FBS,PPBS,HBA1C

3.LIPID PROFILE

4.NCS

5.EMG

6.VITAMIN B12



OVERALL ASESSEMENT



Marked/Very Good Improvement--Above 75% Improvement



Moderate/Good improvement--50-75% Improvement



Mild Improvement--25-50% Improvement



Very Mild Improvement--Below 25%



No Improvement At All----0%

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Male and Female Subjects Of Age Between 25 To 70 Years History Of Diabetes Within 10 Years Diagnosed Cases Of Diabetic Periphearal Neuropathy Who Are Ready To Sign Informed Consent Form Patients Who Are Fit For Basti Siravyadha.

Exclusion Criteria

Neuropathy Due To Other Causes Except Diabetes Patients Having Diabetes Mellitus 1 Patients Having Diabetic Complication Other Than Neuropathy Radiculopathies Also The Subjects Suffering From Severe Systemic Disorders Which Interferes With Course Of Intervention Will Be Excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief From Subjective Parameters Daha, Shula, Chimicgimayana, Supti, Dourbalya( Diabetes Peripheral Neuropathy Symptoms)8 Weeks 3 Days
Secondary Outcome Measures
NameTimeMethod
Nerve conduction Study Changes8 Weeks 3 Days

Trial Locations

Locations (1)

Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary

🇮🇳

Bellary, KARNATAKA, India

Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary
🇮🇳Bellary, KARNATAKA, India
Dr pallavi
Principal investigator
8217453599
pallavidmbidar143@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.